| dalteparin versus UFH | |||
| Scala, 1990 | Dalteparin 120 IU/kg anti-Xa SC twice daily versus Standard heparin continuous IV infusion adaptedto maintain aPTTbetween 1.5 and2.5 times controlvalue | acute myocardial infarction | open Follow-up duration: 7 d |
| UFH versus control | |||
| Handley, 1972 | Heparin 5000 U IV (loading dose) followed by 20 000 U IV twice daily versus no heparin | Myocardial infarction | Follow-up duration: 14 d |
| Handley (low dose), 1972 | Heparin 5000 U IV and 7500 U SC as soon as possible, then 7500 U SC twice daily versus no heparin | Myocardial infarction | Follow-up duration: 7 d |
| Gallus, 1973 | heparin 5000 U SC 3 times daily versus no heparin | Myocardial infarction | Follow-up duration: until mobile |
| Warlow, 1973 | Heparin sodium 5000 U SC twice dailyly versus no heparin | Myocardial infarction | double blind Follow-up duration: 10 d |
| Emerson, 1973 | Heparin Low dose SCium9 versus no heparin | Myocardial infarction | Follow-up duration: NA |
| Zawilska, 1989 | Heparin sodium 5000 IU SC twice dailyy for 14 to 21 days versus no heparin | patients with acute myocardial infarction, disqualified for thrombolytic treatment | Follow-up duration: 14-21 d |
| UFH versus placebo | |||
| Pitt, 1980 | Heparin 500 U IV twice daily versus placebo | patients with acute myocardial infarction of less than 48 hours duration | open Follow-up duration: 2-3 d |
in first
in second
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
